Quick Answer
Silence Therapeutics plc reported Gross Profit of $344.0 thousand for fiscal year 2025.
Silence Therapeutics plc Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $344.0K | -98.9% |
| 2024 | $31.45M | +67.5% |
| 2023 | $18.78M | +129.2% |
| 2022 | $8.19M | +65.2% |
| 2021 | $4.96M | +188.8% |
| 2020 | $1.72M | +603.7% |
| 2019 | $244.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $95.0K | +104.4% | -31.7% |
| June 30, 2025 | $139.0K | +105.4% | +58.0% |
| March 31, 2025 | $88.0K | -99.3% | +104.1% |
| September 30, 2024 | -$2.14M | — | +16.9% |
| June 30, 2024 | -$2.58M | — | -120.0% |
| March 31, 2024 | $12.90M | — | — |
- Silence Therapeutics plc showed a decrease of -98.9% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, Silence Therapeutics plc’s gross profit has grown by 41.0% (from $244.0 thousand to $344.0 thousand).
- The most recent figure is from Silence Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: